Free Trial
OTCMKTS:BICX

Biocorrx Q3 2026 Earnings Results & Report

Biocorrx logo
$0.21 0.00 (0.00%)
As of 11/13/2026 10:26 AM Eastern

Biocorrx beat analyst earnings expectations in its Q3 2026 results, released November 16, 2026. The company reported EPS of -$0.03 versus the -$0.05 consensus estimate.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens

Biocorrx EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 5 quarters

Biocorrx Revenue Results

Actual Revenue
N/A
Expected Revenue
$250 thousand
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Biocorrx Q3 2026 Earnings FAQ

Biocorrx (OTCMKTS:BICX) reported earnings of -$0.03 per share for Q3 2026, beating the consensus estimate of -$0.05. The report was announced on Monday, November 16, 2026.

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biocorrx on the company's earnings history page.

Biocorrx Earnings Headlines

Biocorrx (BICX) Projected to Release Quarterly Earnings on Tuesday
BioCorRx Inc
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
BioCorRx Inc.
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence.

The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

BioCorRx has also offered UnCraveRx, a medically supervised weight-management program. Its activities are centered on treatment and support services rather than traditional pharmaceutical manufacturing or general medical care.

View Biocorrx Profile